ONYX Therapeutics Champion – A Phase 1/2 Phase Study of Weekly Carfilzomib in Combination with Dexamethazone for Progressive Multiple Myeloma

ONYX Therapeutics Champion – A Phase 1/2 Phase Study of Weekly Carfilzomib in Combination with Dexamethazone for Progressive Multiple Myeloma

CHAMPION
Hematology (Blood)
Saad Jamshed, MD
Enrolling
Rachel O'Loughlin, RN
(585) 747-4555
(585) 922-5665